Evidence map›Paper›PMID 39559092›Full record

ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2024

The Predictive Value of NLR, PLR and SII for SSNHL in Children and Young Adults.

Yali Liu, Guowei Ma, Yumei Li, Yuanyuan Wu

Abstract read
In one paragraph

Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yali LiuENT Department, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei China.
Guowei MaSchool of Pharmacy, Department of Pharmacology, China Medical University, Shenyang, Liaoning China.
Yumei LiENT Department, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei China.
Yuanyuan WuENT Department, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei China.ORCID 0009-0006-3787-8599

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sudden Sensorineural Hearing Loss is a common emergency in otolaryngology, with an increasing incidence among younger age groups. This study retrospectively analyzes peripheral blood inflammatory markers in SSNHL patients under 24 years-old to explore the potential prognostic value of the immune inflammatory response in young SSNHL patients. This retrospective analysis included 53 SSNHL patients who received treatment from January 2016 to December 2023. Patients were grouped based on age, gender, and therapeutic effects. Sixty-two healthy volunteers were selected from the hospital physical examination center as the control group. Neutrophil, lymphocyte, and platelet counts were measured to calculate the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Systemic Immune-Inflammation Index (SII). Logistic regression models determined prognostic risk variables, and receiver operating characteristic (ROC) curves calculated the model's predictive accuracy. Compared to the control group, SSNHL patients exhibited increased absolute neutrophil counts, platelet counts, NLR, PLR, and SII, while lymphocyte counts decreased. Male patients showed statistical differences in neutrophil counts, NLR, PLR, and SII, while female patients showed statistical differences in neutrophil counts, NLR, and SII. Statistical differences were observed in platelet counts between males aged ≤ 18 and lymphocyte counts in males aged 18-24. Significant differences in neutrophil counts, NLR, and SII were found between effective and ineffective treatment groups for SSNHL patients aged 18-24. Elevated SII was identified as a risk factor affecting the efficacy of SSNHL treatment in patients aged 18-24. Chronic inflammation is a confirmed pathological and physiological process in SSNHL, necessitating hormone anti-inflammatory therapy for both adults and children. Supplementary Information: The online version contains supplementary material available at 10.1007/s12070-024-04985-1.

Indexed as

ChildrenInflammationSSNHLYouth

Identifiers

PMID39559092
PMCPMC11569354

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.